Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

NVS Relative to the S&P 500

NVS Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Novartis A G (NYSE:NVS) seasonal charts above shows that a Buy Date of April 3 and a Sell Date of August 19 has resulted in a geometric average return of 2.01% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 15 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 4.42% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Novartis develops and manufactures innovative drugs. The firm’s key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.

To download NVS seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: NVS